Nervenheilkunde 2018; 37(11): 835-836
DOI: 10.1055/s-0038-1675716
Verschiedenes
Georg Thieme Verlag KG Stuttgart · New York

Kopfschmerz News

Deutsche Migräne- und Kopfschmerzgesellschaft
Further Information

Publication History

Publication Date:
30 October 2018 (online)

 

 


#
  • Literatur

  • 1 Cernuda-Morollón E. et al. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 2013; 81 (14) 1191-1196.
  • 2 Cernuda-Morollón E. et al. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine. Headache 2014; 54: 987-95.
  • 3 Edvinsson L. et al. CGRP as the target of new migraine therapies – successful translation from bench to clinic. Nature Reviews Neurology 2018; 14 (06) 338.

  • Literatur

  • 1 Cernuda-Morollón E. et al. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 2013; 81 (14) 1191-1196.
  • 2 Cernuda-Morollón E. et al. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine. Headache 2014; 54: 987-95.
  • 3 Edvinsson L. et al. CGRP as the target of new migraine therapies – successful translation from bench to clinic. Nature Reviews Neurology 2018; 14 (06) 338.